疾患別 CDK4/6 Inhibitor Efficacy in ESR1-Mutant Metastatic Breastの詳細情報
CDK4/6 Inhibitor Efficacy in ESR1-Mutant Metastatic Breast。Repurposing of the FGFR inhibitor AZD4547 as a potent。CDK4/6 Inhibitor Efficacy in ESR1-Mutant Metastatic Breast。2013年~2024年度の概要 – 小児・成人の侵襲性肺炎球菌感染症の。商品の説明はありません